News

LLY, NVO: Which GLP-1 Stock Is the Better Bet?

The GLP-1 (weight-loss drug) boom is continuing to gain steam. As the two leaders in the space, Eli Lilly (LLY) and Novo Nordisk (NVO) stand out as top picks for investors to play the trend. Though the two biotech innovators have felt the pressure from the July-August market sell-off, high demand and efforts to ramp up production seem to be setting the stage for a glorious growth surge at some point over the near future. As always, though, one firm may be in better shape than the other to seize

Lenovo Q1 revenue jumps 20%, beats estimates as PC market recovers

China's Lenovo Group reported a 20% rise in its quarterly revenue on Thursday, as the global personal computer market showed signs of recovery after a two-year slump. For the three months ended in June, the company's revenue rose to $15.4 billion, above the average estimate of $14.1 billion expected by analysts polled by LSEG. This marks a third consecutive quarter of revenue growth for Lenovo after it suffered five straight quarters of revenue declines amid the post-COVID slowdown.

McDonald’s Stock (NYSE:MCD): Comparable Sales Turn Red — Now What?

McDonald’s (MCD) shares have declined by 7.4% year-to-date, mainly due to enduring bearish sentiment sustained by decelerating comparable sales, which even dipped into negative territory in its most recent Q2 results. This, in turn, can be largely attributed to wider industry trends and factors beyond McDonald’s control. Despite this, the company is on track to see record sales and near-record earnings this year, all while trading at an attractive valuation. Thus, I am bullish on MCD stock and b